NO883342L - Fremgangsmaate for fremstilling av terapeutisk anvendbart trombinkonsentrat. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk anvendbart trombinkonsentrat.

Info

Publication number
NO883342L
NO883342L NO88883342A NO883342A NO883342L NO 883342 L NO883342 L NO 883342L NO 88883342 A NO88883342 A NO 88883342A NO 883342 A NO883342 A NO 883342A NO 883342 L NO883342 L NO 883342L
Authority
NO
Norway
Prior art keywords
concentrate
preparation
trombine
procedure
therapeutic
Prior art date
Application number
NO88883342A
Other languages
English (en)
Other versions
NO883342D0 (no
NO174929C (no
NO174929B (no
Inventor
Myriana Burnouf
Thierry Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Publication of NO883342D0 publication Critical patent/NO883342D0/no
Publication of NO883342L publication Critical patent/NO883342L/no
Publication of NO174929B publication Critical patent/NO174929B/no
Publication of NO174929C publication Critical patent/NO174929C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO883342A 1987-07-30 1988-07-28 Fremgangsmåte for fremstilling av et lett opplöselig konsentrat av trombinkoagulerbare proteiner NO174929C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8710798A FR2618784B1 (fr) 1987-07-30 1987-07-30 Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique

Publications (4)

Publication Number Publication Date
NO883342D0 NO883342D0 (no) 1988-07-28
NO883342L true NO883342L (no) 1989-01-31
NO174929B NO174929B (no) 1994-04-25
NO174929C NO174929C (no) 1994-08-03

Family

ID=9353711

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883342A NO174929C (no) 1987-07-30 1988-07-28 Fremgangsmåte for fremstilling av et lett opplöselig konsentrat av trombinkoagulerbare proteiner

Country Status (10)

Country Link
EP (1) EP0305243B1 (no)
JP (1) JP2787317B2 (no)
AT (1) ATE73341T1 (no)
CA (1) CA1341376C (no)
DE (1) DE3869018D1 (no)
DK (1) DK173568B1 (no)
ES (1) ES2039666T3 (no)
FR (1) FR2618784B1 (no)
GR (1) GR3004047T3 (no)
NO (1) NO174929C (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0431072Y2 (no) * 1988-03-14 1992-07-27
FR2639958B1 (fr) * 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7196054B1 (en) 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
DE4202667C1 (no) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
WO1994002183A1 (en) * 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
DK0835667T3 (da) 1996-03-15 2005-12-05 Chemo Sero Therapeut Res Inst Vævklæbemiddel egnet til spröjtepåföring
WO1998055140A1 (en) * 1997-06-05 1998-12-10 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
FR2894831B1 (fr) 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
FR2952641B1 (fr) 2009-11-18 2012-01-13 Lfb Biomedicaments Procede de traitement du plasma sanguin comprenant une etape de lavage par dispersion
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
EP3307237A1 (en) 2015-06-12 2018-04-18 Laboratoire Français du Fractionnement et des Biotechnologies Injectable composition of factor vii and fillers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156681A (en) * 1974-03-28 1979-05-29 Plasmesco Ag Process for isolating albumin from blood
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
EP0068048B1 (de) * 1981-06-25 1985-06-19 Serapharm GmbH & Co. KG Angereichertes Plasmaderivat zur Unterstützung von Wundverschluss und Wundabdeckung
US4374061A (en) * 1981-07-27 1983-02-15 Center For Blood Research, Inc. Means and methods for purifying Clq, Clr and Cls
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE3228502A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung des c1-inaktivators und seine verwendung
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives

Also Published As

Publication number Publication date
NO883342D0 (no) 1988-07-28
CA1341376C (fr) 2002-07-16
GR3004047T3 (no) 1993-03-31
ES2039666T3 (es) 1993-10-01
FR2618784B1 (fr) 1990-04-06
DE3869018D1 (de) 1992-04-16
JPH02114A (ja) 1990-01-05
DK424188A (da) 1989-01-31
EP0305243A1 (fr) 1989-03-01
EP0305243B1 (fr) 1992-03-11
NO174929C (no) 1994-08-03
JP2787317B2 (ja) 1998-08-13
FR2618784A1 (fr) 1989-02-03
DK424188D0 (da) 1988-07-29
NO174929B (no) 1994-04-25
ATE73341T1 (de) 1992-03-15
DK173568B1 (da) 2001-03-19

Similar Documents

Publication Publication Date Title
NO883342D0 (no) Fremgangsmaate for fremstilling av terapeutisk anvendbart trombinkonsentrat.
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
DE69224768D1 (de) Expression von menschlichen Serum-Albuminen in Pichia pastoris
NO902947L (no) Termoplastisk bearbeidbar stivelse saavel som fremgangsmaate for fremstilling.
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
NO905264L (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
SE8902376D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
DE3580283D1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
NO175149C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, eventuelt ddiksyrer og -estere
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
WO1987000521A3 (fr) Nouveaux derives d'acide carboxylique, leur procede de fabrication, leur utilisation, et medicaments contenant ces composes
ATE67212T1 (de) Thiazolidin-4-carbonsaeurederivat, seine herstellung und pharmazeutische zusammensetzungen, die dieses enthalten.
NO180636C (no) Fremgangsmåte for fremstilling av et rent O-glycosylert IGF-1
DE68908913D1 (de) Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.
HUT59136A (en) Process for producing 3-(pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives
DE68924011D1 (de) Verfahren zur Herstellung von Pyrazolkarbonsäure und Derivaten.
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
UA7730A1 (uk) Засіб одержання складного етілового ефіра аповінкамінової кислоти
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3851669D1 (de) Verwendung von Gepiron für Medikamente zur Milderung panischer Zustände.
ATE16078T1 (de) Zusammensetzung fuer die ovulationskontrolle bei weiblichen rindern.
KR830009733A (ko) 유부(乳腐)제조방법
HAMAZAKI et al. Collagen-coated glass beads containing glycerine for the measurement of platelet adhesion and inhibition of platelet adhesion by dilazep
CA2170600A1 (en) Wound covering material and wound covering composition
ATE57835T1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.

Legal Events

Date Code Title Description
MK1K Patent expired